Festival of Biologics USA 2024: April 15-17
Thank you to those who joined us at the Festival of Biologics USA 2024 from April 15-17 in San Diego, CA!
Our Poster titled “Generation of a TAA Antibody Library to Support the Development of Antibody-Drug Conjugates (ADC)” is now available for download using the link below.
Poster Summary:
Biocytogen’s antibody discovery team has generated a library of antibodies targeting approximately 200 tumor-associated antigens (TAAs) using three RenMice® platforms – RenMabTM, RenLite®, and RenNano®. RenMice generate fully human antibodies, facilitating the discovery and development of therapeutic monoclonal antibodies, bispecific/multispecific antibodies, and single-domain antibodies. Engineered with a specific target gene knocked out, RenMice® are designed to trigger potent immune responses against homologous proteins and produce antibodies that bind more broadly to epitopes, increasing the chance of discovering antibodies with enhanced therapeutic potential. Many of the TAA-targeting antibodies discovered from RenMice have been screened for internalization activity to ensure suitability for ADC development. This ready-to-use resource expedites the development of antibody-drug conjugates (ADCs) across various modalities.
The Festival of Biologics brings together pharma & biotech, academics, and research institutes, together with their partners across the value chain. Across antibodies, immunotherapy, and biosimilars our participants share research, create new partnerships, and tackle the clinical trials, manufacturing, and commercial challenges involved in bringing new therapies to market.
Event Date: April 15-17, 2024 | Event Location: San Diego, CA
